Open AccessCompletion lymphadenectomy for sentinel node positive cutaneous head & neck melanoma
Author(s) -
Schmalbach Cecelia E.,
Bradford Carol R.
Publication year - 2018
Publication title -
laryngoscope investigative otolaryngology
Language(s) - English
Resource type - Journals
ISSN - 2378-8038
DOI - 10.1002/lio2.136
Subject(s) - medicine , sentinel lymph node , lymphadenectomy , melanoma , head and neck , sentinel node , dissection (medical) , biopsy , randomized controlled trial , lymph node , general surgery , surgery , radiology , cancer , cancer research , breast cancer
The application and utility of melanoma sentinel lymph node biopsy (SLNB) has evolved significantly since its inception over two decades ago. The current focus has shifted from a staging modality to potentially a therapeutic intervention. Recent research to include large multi‐institutional randomized trials have attempted to answer the question: is a completion lymph node dissection (CLND) required following a positive SLNB? This review provides an evidence‐based, contemporary review of the utility of CLND for SLNB positive head and neck cutaneous melanoma patients. Level of Evidence NA